EXPENSIFY INC - A
EXFYNASDAQ๐ #3491 by market capEarnings Nov 5 ยท PostUS Equity
$2.43โผ $0.06 (โ2.61%)
๐ After hours$2.43โฒ 0.21%Regular close ยท extended-hours price shownTrack EXFY
Get earnings, price moves & breaking news on Telegram
24hโผ 2.6%
7dโผ 6.4%
14dโฒ 0.4%
30dโฒ 7.3%
ytdโฒ 60.6%
1yโฒ 52.5%
๐ฆMarket Cap
$234M
Small Cap
๐Revenue Growth (YoY)
2.1%
Slowing
๐Gross Margin
48.7%
Healthy
๐ตFCF Margin
9.7%
Moderate
โ๏ธP/S Ratio
1.7x
Cheap
Otter Score
โ
Insufficient data
EXPENSIFY INC - A
EXFYAnalyst Ratings
Price
$2.43
Total
10
Raised
2
Lowered
3
Avg PT
$13.75
H / L
$25 / $3
| Institution | Action | Rating | Date | Upside | |
|---|---|---|---|---|---|
Citizens | Upgraded | Market Perform โ Market Outperform | 2026-08-07 | โ | โ |
Lake Street | Reiterated | Buy | 2025-05-09 | โ | โ |
Citigroup | Reiterated | Buy | 2024-12-16 | โ | โ |
JMP Securities | Downgraded | Market Outperform โ Market Perform | 2024-11-25 | $2.50 | +3.10% |
Piper Sandler | Reiterated | Neutral | 2024-02-23 | โ | โ |
Morgan Stanley | Reiterated | Underweight | 2023-11-08 | โ | โ |
Loop Capital | Downgraded | Buy โ Hold | 2023-08-09 | โ | โ |
BMO Capital | Downgraded | Outperform โ Market Perform | 2023-05-10 | $25.00 | +930.90% |
B of A Securities | Upgraded | Neutral โ Buy | 2022-07-18 | โ | โ |
JP Morgan | Reiterated | Overweight | 2022-06-15 | โ | โ |
Institution
Citizens
Upgraded ยท Market Perform โ Market Outperform ยท 2026-08-07
โ
โ
Lake Street
Reiterated ยท Buy ยท 2025-05-09
โ
โ
Citigroup
Reiterated ยท Buy ยท 2024-12-16
โ
โ
JMP Securities
Downgraded ยท Market Outperform โ Market Perform ยท 2024-11-25
$2.50
+3.10%
Piper Sandler
Reiterated ยท Neutral ยท 2024-02-23
โ
โ
Morgan Stanley
Reiterated ยท Underweight ยท 2023-11-08
โ
โ
Loop Capital
Downgraded ยท Buy โ Hold ยท 2023-08-09
โ
โ
BMO Capital
Downgraded ยท Outperform โ Market Perform ยท 2023-05-10
$25.00
+930.90%
B of A Securities
Upgraded ยท Neutral โ Buy ยท 2022-07-18
โ
โ
JP Morgan
Reiterated ยท Overweight ยท 2022-06-15
โ
โ
One row per institution ยท price target from the firm's latest published target